Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1. Read more about Targeting a splicing-mediated drug resistance mechanism in prostate cancer by inhibiting transcriptional regulation by PKCβ1.
Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer. Read more about Molecular characteristics and clinical outcomes of patients with Neurofibromin 1-altered metastatic colorectal cancer.
DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway. Read more about DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.
MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK. Read more about MicroRNA-155 contributes to plexiform neurofibroma growth downstream of MEK.
Functional characterization of uveal melanoma oncogenes. Read more about Functional characterization of uveal melanoma oncogenes.
MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer. Read more about MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer.
Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis. Read more about Increased baseline RASGRP1 signals enhance stem cell fitness during native hematopoiesis.
Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability. Read more about Mortalin/HSPA9 targeting selectively induces KRAS tumor cell death by perturbing mitochondrial membrane permeability.
Correction: The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20. Read more about Correction: The pleiotropic effects of TNFα in breast cancer subtypes is regulated by TNFAIP3/A20.
APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma. Read more about APOBEC-induced mutations and their cancer effect size in head and neck squamous cell carcinoma.
